Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA site-wide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the previous content, replacing the detailed study information with a minimal error page.SummaryDifference17%

- Check49 days agoChange DetectedThe page's revision tag changed from v3.6.6 to v3.7.0, representing an update to the page rendering or underlying system. This is a maintenance update and does not modify the study details or results presented on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a new build of the ClinicalTrials.gov page. This is a backend update that does not change the study details or data shown for NCT04541043.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the underlying version without altering displayed study information.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.